COMPOUNDS THAT MODULATE PROCESSES ASSOCIATED WITH IgE PRODUCTION AND METHODS AND KITS FOR IDENTIFYING AND USING THE SAME

Details for Australian Patent Application No. 2003225727 (hide)

Owner RIGEL PHARMACEUTICALS, INC.

Inventors WARNER, Justin, E.; ANDERSON, David, C.; KINSELLA, Todd, M.; MASUDA, Esteban; BENNET, Mark, K.

Pub. Number AU-A-2003225727

PCT Number PCT/US03/07243

PCT Pub. Number WO2003/075859

Priority 10/095,659 08.03.02 US; 10/098,243 15.03.02 US

Filing date 7 March 2003

Wipo publication date 22 September 2003

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 10/095,659 08.03.02 US; 10/098,243 15.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003225727

9 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225728-CRYSTALLOGRAPHIC METROLOGY AND PROCESS CONTROL

2003225726-Novel metabolic targets and markers